Siste oppdatering :
19/11/2024
Kurarelignende middel   Suxamethonium chloride  
Injeksjon
Oppløsningsstabilitet Stabilitet i blandinger Faktorer som påvirker stabiliteten Kompatibilitet Administrasjonsmåte Referanser pdf
   Kjemisk struktur  

Handelsnavn   Handelsnavn     

Handelsnavn er veiledende og sammensetning av hjelpestoffer kan være forskjellig avhengig av land og produsent

Actirelax Argentina
Anectine De forente arabiske emirater, Irland, Mexico, Spania, Storbritannia, USA
Celocurin Sverige
Celocurine Belgia, Frankrike
Chlorsucillin Polen
Cholsuxinyl Egypt
Cloruro de succinilcolina Argentina
Cloruro de suxametonio Peru
Curacit Norge
Distensil Peru
Entubate India
Ethicoline Malaysia
Fosfitone Argentina, Venezuela
Lycitrope Hellas
Lysthenon De forente arabiske emirater, Romania, Saudi-Arabia, Sveits, Tyskland, Østerrike
Midarine Italia, Saudi-Arabia, Sveits
Mioflex Portugal, Spania
Miokolin Iran
Myoplegine Belgia, Luxembourg
Myotenlis Italia
Pantolax Tyskland
Quelicin Colombia
Succi Argentina
Succinilcholina Argentina
Succinilcholina cloruro Peru
Succinolin Sveits
Succinyl Luxembourg
Succinylcholine Canada, Iran, Tyskland
Succyl Iran
Sukolin Finland
Suxamethonium Australia, Iran, Irland, Malaysia, New Zealand, Storbritannia
Suxametonio cloruro Chile, Peru
Suxim Peru
Uxicolin Colombia, Mexico
Referanser   Injeksjon   Referanser : Suxamethonium chloride  
Type publikasjon
45 Journal Schmutz CW, Mühlbach SF.
Stability of succinylcholine chloride injection.
Am J Hosp Pharm 1991 ; 48: 501-506.
300 Journal Trissel LA, Gilbert DL, Martinez JF.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
319 Journal Hadzija BW, Lubarsky DA.
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Am J Health-Syst Pharm 1995 ; 52: 997-999.
667 Journal Pramar YV, Moniz D, Hobbs D.
Chemical stability and adsorption of succinylcholine chloride injections in disposable plastic syringes.
J Clin Pharm Ther 1994 ; 19: 195-198.
1050 Journal Boehm JJ, Dutton DM, Poust RI.
Shelf life of unrefrigerated succinylcholine chloride injection.
Am J Hosp Pharm 1984 ; 41: 300-302.
1721 Journal Trissel LA, Williams KY, Baker MB.
Compatibility screening of Hextend during simulated Y-site administration with other drugs.
Int J Pharm Compound 2001 ; 5: 69-72.
1755 Journal Storms ML, Stewart JT, Warren FW.
Stability of succinylcholine chloride injection at ambient temperature and 4°C in polypropylene syringes.
Int J Pharm Compound 2003 ; 7: 68-70.
2215 Journal Boehm J.J, Poust R.I.
Hydrolysis of succinylcholine chloride in pH range 3.0 to 4.5.
Chem Pharm Bull 1984 ; 32, 3: 1113-1119.
2227 Journal Trusley C, Ben M, Kupiec TC, Trissel LA.
Compatibility and stability of palonosetron hydrochloride with four neuromuscular blocking agents during simulated Y-site administration.
Int J Pharm Compound 2008 ; 12, 2: 156-160.
2360 Journal Roy J.J, Boismenu D, Mamer O.A, Nguyen B.T, Forest J.M, Hildgen P.
Room temperature stability of injectable succinylcholine dichloride.
Int J Pharm Compound 2008 ; 12, 1: 83-85.
3373 Journal Khan S, Stannard N, Greijn J.
Precipitation of thiopental with muscle relaxants: a potential hazard.
J R Soc Med Sh Rep 2011 ; 2: 58.
3631 Labratorium Suxamethonium (Suxamethonium Aguettant®) - Résumé des caractéristiques du produit
Aguettant 2016
3932 Labratorium Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit
Serb Laboratoire 2015
4274 Journal Beck W, Kabiche S, Balde I-B, Carret S, Fontan J-E, Cisternino S, Schlatter J.
Stability of suxamethonium in pharmaceutical solution for injection by validated stability-indicating chromatographic method.
J Clin Anesth 2016 ; 35: 551-559.
4528 Journal Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Int J Pharm Compound 2021 ;25,1:52-61

  Mentions Légales